Literature DB >> 16618259

The role of cardiac and pulmonary pathology in migraine: a hypothesis.

Peter Wilmshurst1, Simon Nightingale.   

Abstract

From observation of recent data linking migraine with right-to-left shunts and by analogy with the etiologies of decompression illness, we postulate that cardiac and pulmonary pathology can have an important effect on the cranial final common pathway that generates attacks of migraine. One possible mechanism is associated with a significant right-to-left shunt, which is usually through a persistent foramen ovale, but is sometime through a pulmonary shunt. This allows a venous agent, possibly 5-hydroxytryptamine, to bypass the lung filter. Migraine can occur when there is no shunt if similar agents are liberated in the left heart beyond the lung filter, possibly by platelet activation. Migraine could also occur if the venous agents are produced in such large amounts that they overwhelm the pulmonary filter or are unaffected by passage through the lungs. In some individuals migraine may be unrelated to blood-borne triggers.

Entities:  

Mesh:

Year:  2006        PMID: 16618259     DOI: 10.1111/j.1526-4610.2006.00374.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  20 in total

1.  Congenital heart conditions: the 'headache' of assessing a link between PFO and migraine.

Authors:  Gianluca Rigatelli
Journal:  Nat Rev Cardiol       Date:  2010-07       Impact factor: 32.419

Review 2.  Closure of patent foramen ovale in the prevention of migraine: not enough evidence in favor.

Authors:  Markus Schürks; Hans-Christoph Diener
Journal:  Nat Clin Pract Neurol       Date:  2008-12-02

Review 3.  Patent foramen ovale and migraine: an example of heart-brain interaction.

Authors:  Gian Paolo Anzola
Journal:  Nat Clin Pract Neurol       Date:  2008-12-02

Review 4.  Current management aspects in adult congenital heart disease: non-surgical closure of patent foramen ovale.

Authors:  Kaivan Vaidya; Chinmay Khandkar; David Celermajer
Journal:  Cardiovasc Diagn Ther       Date:  2018-12

Review 5.  Current status of percutaneous PFO closure.

Authors:  N Rohrhoff; J P Vavalle; S Halim; T L Kiefer; J K Harrison
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

6.  Migraine headaches following catheter ablation for atrial fibrillation.

Authors:  Amit Noheria; John Roshan; Suraj Kapa; Komandoor Srivathsan; Douglas L Packer; Samuel J Asirvatham
Journal:  J Interv Card Electrophysiol       Date:  2010-10-19       Impact factor: 1.900

7.  Migraine with aura and persistent foramen ovale.

Authors:  P T Wilmshurst
Journal:  Eye (Lond)       Date:  2017-12-08       Impact factor: 3.775

8.  A right-to-left shunt and prothrombotic disorders in pediatric patients presenting with transient ischemic attack.

Authors:  Mirjana Perkovič-Benedik; Marjan Zaletel; Nuška Pečarič-Meglič; Tomaž Podnar
Journal:  Eur J Pediatr       Date:  2012-10-30       Impact factor: 3.183

Review 9.  Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects.

Authors:  Simona Sacco; Davide Cerone; Antonio Carolei
Journal:  J Headache Pain       Date:  2008-07-04       Impact factor: 7.277

10.  Migraine, cerebrovascular disease and the metabolic syndrome.

Authors:  Alexandra J Sinclair; Manjit Matharu
Journal:  Ann Indian Acad Neurol       Date:  2012-08       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.